Johnson & Johnson: Epilepsy trials

The registry lists 30 Epilepsy studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 7Phase 3 12Phase 4 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With EpilepsyCompletedNCT02201251Phase 3Results posted
• A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With EpilepsyCompletedNCT01689649Phase 4Results posted
• An Observational Study to Evaluate Long-term Retention Rate of Topiramate in Participants With EpilepsyCompletedNCT01682681Results posted
• First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical PatientsCompletedNCT01627860Phase 4Results posted
• A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With EpilepsyCompletedNCT01030094
• A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy AdultsCompletedNCT00701493Phase 1
• Study on Migraine and Headache in Epileptic PatientsCompletedNCT00642564
• A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive EpilepsyCompletedNCT00579384Phase 2
• A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With SeizuresCompletedNCT00297349
• An Observational Study of the Safety of Topiramate in Adults and Children With EpilepsyCompletedNCT00297323
• A Study of the Prevalence of Headache in Epileptic PatientsCompletedNCT00277368
• A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of EpilepsyCompletedNCT00266604Phase 4
• A Study of the Efficacy and Safety of Topiramate Treatment in Patients With EpilepsyCompletedNCT00266591Phase 3
• Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy PatientsCompletedNCT00236886Phase 3
• A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.CompletedNCT00236873Phase 2
• A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset SeizuresCompletedNCT00236860Phase 2
• A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.CompletedNCT00236847Phase 2
• A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut SyndromeCompletedNCT00236756Phase 3
• A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With EpilepsyCompletedNCT00236743Phase 3
• A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control EpilepsyCompletedNCT00236730Phase 2
• A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With EpilepsyCompletedNCT00236717Phase 3
• A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresCompletedNCT00236704Phase 3
• A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.CompletedNCT00236691Phase 2
• A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresCompletedNCT00236418Phase 3
• A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent EpilepsyCompletedNCT00231556Phase 3
• A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset SeizureCompletedNCT00230698Phase 3
• Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic EpilepsyCompletedNCT00216567Phase 4
• A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug TreatmentCompletedNCT00210782Phase 3
• A Pilot Study of Topiramate in Childhood Absence EpilepsyCompletedNCT00210574Phase 2
• Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset SeizuresCompletedNCT00113815Phase 3